 GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 GLOBE NEWSWIRE -- Applied Genetic Technologies Corporation Nasdaq: AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus AAV-based gene therapies for the treatment of rare inherited retinal diseases IRDs, today announced Sue Washer, President and Chief Executive Officer of AGTC, will present at the 2021 Cell Gene Meeting on the Mesa being held October 12-14, 2021. 